SC-004

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSC-004

Drug Alias NameSC-004

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionCell wall inhibitorsAnti-Claudin-9Anti-CLDN6

TargetsClaudin-9Claudin 6

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAbbvie Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A